Correction: Real-world experience with molnupiravir during the period of SARS-CoV-2 Omicron variant dominance.
Pharmacol Rep
; 74(6): 1328, 2022 Dec.
Article
en En
| MEDLINE
| ID: mdl-36190677
Texto completo:
1
Banco de datos:
MEDLINE
Idioma:
En
Año:
2022
Tipo del documento:
Article